The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 862.00
Bid: 856.00
Ask: 861.00
Change: 20.00 (2.38%)
Spread: 5.00 (0.584%)
Open: 827.00
High: 862.00
Low: 821.00
Prev. Close: 842.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

1 Oct 2019 11:30

RNS Number : 2394O
JTC PLC
01 October 2019
 

1 October 2019

 

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Issue of Shares and Total Voting Rights

 

JTC today announces that it has allotted and issued 1,128,210 new Ordinary Shares of £0.01 each in the capital of the Company (the "New Shares"). The New Shares have been allotted and issued to the JTC PLC Employee Benefit Trust ("EBT") at the par value of £0.01 each, in order to satisfy future exercises of awards granted to beneficiaries under the rules of the EBT.

The EBT now holds a total of 2,227,988 ordinary shares of £0.01 each in the capital of the Company, representing 1.95 per cent. of the issued share capital.

In relation to the above, applications have been made to the Financial Conduct Authority for admission of the New Shares to the premium listing segment of the Official List of the Financial Conduct Authority and to London Stock Exchange plc for admission to trading of the New Shares on its main market for listed securities (together, "Admission"). The Admission is expected to take place at 8.00 a.m. on Wednesday 2 October 2019.

Following admission of the New Shares the Company will have 113,949,187 Ordinary Shares of £0.01 each in issue. There are no shares held in treasury. Therefore, following admission of the New Shares the total number of voting rights in the Company will be 113,949,187 (the "Voting Rights Figure"), and this Voting Rights Figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Miranda Lansdowne

JTC (Jersey) Limited

Joint Company Secretary

+44 1534 700 000

Miranda.Lansdowne@jtcgroup.com

 

About JTC

JTC is an award-winning provider of fund, corporate and private wealth services to institutional and private clients. The Company has a global presence, with over 700 staff operating in more than 18 different jurisdictions and assets under administration totalling c. US$ 110+ billion.

JTC remains fully committed to its shared ownership culture and philosophy, with management and staff continuing to hold over 20% of the equity in the firm, clearly aligning the interests of clients, employees and other stakeholders.

www.jtcgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKKDNOBKDNCN
Date   Source Headline
10th Apr 201912:02 pmRNSPrice Monitoring Extension
8th Apr 20194:50 pmRNSHolding(s) in Company
8th Apr 20198:53 amRNSHolding(s) in Company
5th Apr 20199:15 amRNSPDMR/PCA Shareholding Notification
4th Apr 201910:12 amRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSGrant of Conditional Share Awards
3rd Apr 20191:04 pmRNSDirector/PDMR Shareholding
3rd Apr 201912:47 pmRNSDirector/PDMR Shareholding
3rd Apr 20197:00 amRNSFull year results to 31 December 2018
26th Mar 20197:00 amRNSAcquisition of Exequtive Partners S.A.
24th Jan 20197:00 amRNSTrading Update
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
24th Dec 201812:40 pmRNSSecond Price Monitoring Extn
24th Dec 201812:35 pmRNSPrice Monitoring Extension
18th Dec 201812:07 pmRNSSecond Price Monitoring Extn
18th Dec 201812:02 pmRNSPrice Monitoring Extension
29th Nov 20182:52 pmRNSDirector/PDMR Shareholding
21st Nov 201812:07 pmRNSSecond Price Monitoring Extn
21st Nov 201812:02 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSCompletion of acquisition and equity issue
9th Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20184:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 20183:39 pmRNSDirector/PDMR Shareholding
27th Sep 20189:30 amRNSIssue of Equity and Completion of Acquisition
25th Sep 20189:52 amRNSHolding(s) in Company
24th Sep 201810:06 amRNSHolding(s) in Company
24th Sep 201810:05 amRNSHolding(s) in Company
19th Sep 201811:31 amRNSDirector/PDMR Shareholding
19th Sep 201810:28 amRNSGrant of Conditional Share Awards
18th Sep 20187:00 amRNSInterim results for the 6 months ended 30 June 18
6th Sep 20187:00 amRNSAcquisition of Minerva
17th Aug 20187:00 amRNSAcquisition of Van Doorn CFS B.V.
24th Jul 20185:38 pmRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading Update
16th Jul 201812:51 pmRNSDirector/PDMR Shareholding
12th Jul 201810:03 amRNSHolding(s) in Company
3rd Jul 201810:26 amRNSHolding(s) in Company
3rd Jul 201810:25 amRNSHolding(s) in Company
22nd Jun 201811:32 amRNSBroker Appointment
19th Jun 20183:43 pmRNSNotice of Results
19th Jun 201811:57 amRNSHolding(s) in Company
13th Jun 20182:02 pmRNSHolding(s) in Company
22nd Mar 201811:15 amRNSHolding(s) in Company
19th Mar 20182:48 pmRNSHolding(s) in Company
19th Mar 20182:33 pmRNSHolding(s) in Company
19th Mar 20182:33 pmRNSHolding(s) in Company
16th Mar 20181:08 pmRNSDirector/PDMR Shareholding
16th Mar 20181:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.